ProShares S&P 500 Ex-Health Care ETF
The ETF.net SPXV Grade
B
Score 63 out of 100
- 12 of 29
Score 63 of 100 falls in the B band. A is 70 or higher, B 55 to under 70, C 40 to under 55, D 25 to under 40, F under 25.
Cost
The fund’s net expense ratio, ranked against its category.A73 out of 100Rank 7 of 29Mission
Whether the fund did what it promised, tested against its stated mandate.A95 out of 100Rank 11 of 22Risk
How the fund held up when markets fell: downside volatility, drawdowns and tail loss.D38 out of 100Rank 23 of 29Tradability
How easy the fund is to trade: daily volume, and how far its price strays from net asset value.D33 out of 100Rank 23 of 29Holdings
How concentrated the fund is, and how complete and current its disclosed holdings are.C45 out of 100Rank 20 of 28Durability
Whether the fund is likely to stay open, judged by its age, its assets and its issuer’s assets.B60 out of 100Rank 12 of 29
Our read on SPXV
In short
BThe S&P 500 with one sector surgically removed. SPXV holds roughly 400 large caps and leaves health care out, built for portfolios that already get their pharma and hospital exposure elsewhere.
Stated mandate
The Fund seeks investment results that track the performance of the S&P 500 Ex-Health Care Index before fees and expenses.
Why people hold it
Worth knowing
SPXV Holdings
- Stocks
- 443
- 41%
- AAPL
Sectors
- Technology43.4%
- Financials13.0%
- Consumer Discretionary9.9%
- Communication9.9%
- Industrials8.1%
- Consumer Staples5.2%
- Energy4.3%
- Utilities2.2%
- Materials2.0%
- Real Estate2.0%
Geography
- United States99.46%
- Switzerland0.29%
- China0.11%
- Mexico0.06%
- Ireland0.04%
- United Kingdom0.04%
SPXV Performance
Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.
SPXV$10,997
Returns run to the Oct 30, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.
| Period | SPXV |
|---|---|
| Year to date | +10.4% |
| 1 month | −2.2% |
| 3 months | −0.1% |
| 1 year | +10.0% |
| 3 years | +24.3% |
| 5 years | +12.4% |
| 10 years | +15.5% |
Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.
| Year | Return bar | SPXV |
|---|---|---|
| 2026 YTD | +10.4% | |
| 2025 | +18.4% | |
| 2024 | +28.0% | |
| 2023 | +30.7% | |
| 2022 | −20.4% | |
| 2021 | +28.4% | |
| 2020 | +19.0% |
SPXV in the news
SPXV Dividends
- 0.93%
- $0.76
- $0.18 per share
- Quarterly
SPXV Risk
- 13.3%
How it’s calculated: standard deviation
The sample standard deviation of monthly total returns, multiplied by the square root of 12.
Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.
- 1.38
How it’s calculated: Sharpe ratio
Subtract each month’s Treasury-bill return from the fund’s monthly total return.
Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.
Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.
- −26.6%
How it’s calculated: maximum drawdown
The largest percentage decline from an earlier peak, using total returns with reinvested distributions.
Uses up to five years through the last close, with at least 12 months required.
- 1.07
How it’s calculated: beta
The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.
FMP measures it over up to five years of monthly returns.
SPXV Cost
Overpaying vs BKLC, cheapest in US Large-Cap
$1,898
On $10,000 over 30 years. 7% growth a year before fees, expense ratio only.
SPXV 0.09%
$1,898
BKLC 0.00% Cheapest
$0
Cost over time
Year by year
| Year | SPXV | BKLC | Overpaying |
|---|---|---|---|
| 10 | $165 | $0 | $165 |
| 20 | $646 | $0 | $646 |
| 30 | $1,898 | $0 | $1,898 |
You pay 0.09%Waived by ProShares 0.04%
Full fee 0.13% waiver 0.04% you pay 0.09%
Other funds in US Large-Cap
- BXOEFiShares S&P 500 ex S&P 100 ETFExpense ratio 0.20%1 year return +19.0%
- BIQSUNYLI Candriam U.S. Large Cap Equity ETFExpense ratio 0.09%1 year return +14.1%
- BXLGInvesco S&P 500 Top 50 ETFExpense ratio 0.20%1 year return +3.3%
- BXMAGLarge Cap Ex-Mag 7 ETFExpense ratio 0.35%1 year return +15.7%
- BFEXFirst Trust Large Cap Core AlphaDEX FundExpense ratio 0.57%1 year return +18.8%
